Paid Clinical Trials Quebec City

Discover 354 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 354

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's DiseaseReal-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Recruiting

Sponsor:

AbbVie

Location:

Quebec City, Montreal, Ottawa, Commack NYshow 15 more

Code:

NCT06107426

Conditions

Parkinson's Disease (PD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting

PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Quebec, Montreal, Burlington VT, Portland MEshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Quebec City, Sherbrooke, Montreal, Saint Johnsbury VTshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Quebec, Montreal, Bristol CT, Rochester NYshow 82 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass SurgeryEffect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Recruiting

Sponsor:

Unity Health Toronto

Location:

Quebec, Portland ME, Kingston, New Haven CTshow 5 more

Code:

NCT03900026

Conditions

Coronary Artery Bypass Graft Surgery

Atherosclerosis

Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evolocumab

Placebo

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsA Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Recruiting

Sponsor:

Hoffmann-La Roche

Location:

Quebec, Montreal, Sainte-catherine, Boisbriandshow 25 more

Code:

NCT05476926

Conditions

Neovascular Age-related Macular Degeneration

Diabetic Macular Edema

Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Central Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Faricimab

Port Delivery System with Ranibizumab

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Sainte-foy, Trois-rivieres, Rimouski, Portland MEshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Relieving Chronic Pain in Older Adults with Transcranial Direct Current StimulationRelieving Chronic Pain in Older Adults with Transcranial Direct Current Stimulation

Recruiting

Sponsor:

Université de Sherbrooke

Location:

Quebec, Sherbrooke, Montreal

Code:

NCT05617027

Conditions

Pain, Chronic

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

actual transcranial direct current stimulation (tDCS)

placebo transcranial direct current stimulation (tDCS)

Real-world Clinical Outcomes of the MITRIS RESILIA Mitral ValveReal-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Quebec, Montreal, New York NY, Philadelphia PAshow 19 more

Code:

NCT05526560

Conditions

Mitral Stenosis

Mitral Valve Insufficiency

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MITRIS RESILIA Mitral Valve, Model 11400M

Evaluating Simplified Layered Consent for Clinical TrialsEvaluating Simplified Layered Consent for Clinical Trials

Recruiting

Sponsor:

Sunnybrook Health Sciences Centre

Location:

Quebec, Montreal, Ottawa, Torontoshow 1 more

Code:

NCT06168474

Conditions

Staphylococcus Aureus Bacteremia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Simplified layered consent form

Full-length consent form